Selfdiagnostics SARS-CoV-2 IgM/IgG Antibody Assay Kit

Selfdiagnostics SARS- CoV-2 IgM/IgG Antibody Assay Kit is a lateral flow chromatographic immunoassay for the qualitative detection of IgM and IgG antibodies against SARS CoV-2 in human finger-stick or venipuncture whole blood, serum or plasma specimen in only 15 minutes.

Contact us

Download IFU

Rapid Antibody Multitest


No special equipment
,

transport or storage needed


200 clinical samples tested

3 times more than competitors.


Multiple samples

(finger-stick and venipuncture
whole blood, plasma, serum)

Ideal as a Triage and Screening Tool

  • Doctors, nursing homes, clinics.
  • Labs and COVID-19 wards in hospitals.
  • Triages, emergency departments.
  • Public screening sites etc.

0clinical samples tested

In a clinical study with 200 clinical samples Selfdiagnostics SARS-CoV-2 IgM/IgG Antibody Assay Kit
was compared against confirmed cases of patients with SARS CoV-2 infection. We obtained the following results:

IgG sensitivity > 14 days from infection 97%

IgM sensitivity 7-14 days from infection 84%

Specificity 99%

How does the Selfdiagnostics SARS-CoV-2 IgM/IgG Antibody Assay Kit work?

When the human body comes in contact with foreign antigens, IgM is the earliest antibody produced and its presence is detectable from day 3 after the onset of infection. Therefore, IgM can be used for reflecting whether the body is in an acute state of infection as a main indicator of early diagnosis.

Possible secondary SARS-CoV-2 infection is characterized by elevated SARS-CoV-2 IgG levels. In the majority of cases, IgM levels are also elevated. IgG levels may persist beyond the actual SARS-CoV2 infection. Therefore can indicate a past infection with SARS-CoV2.

Selfdiagnostics SARS-CoV-2 IgM/IgG Antibody Assay Kit
result interpretation

This test is not intended for to diagnose or exclude acute SARS-CoV-2 infection and direct testing should be performed for diagnosis.

Frequently Asked Questions

  • What are IgG and IgM? –The presence of IgM is an indicator of early infection. IgG is a more specialised antibody that specifically binds to the SARS-CoV-2 virus. The presence of IgG is an indicator of later stage infection (usually 7 days or longer after infection).

  • Is the test specific for COVID-19? -The IgG that the test detects is specific to COVID-19, so a positive result would indicate COVID-19 infection. The test can be used for primary and secondary diagnosis of COVID-19.

  • What should I do if I test positive? -If you test positive, you should follow your country’s government’s advice on COVID-19 infection.

  • What if I test negative? –A negative result means the biomarkers are not present in your blood, but you should still exercise caution, as you may still be in the early stages of infection (before IgM levels rise to a detectable level). If symptoms develop, follow the protocols as above and retest as necessary.

Why Selfdiagnostics?

Selfdiagnostics was founded in 2008 by entrepreneurs and scientists to develop new, easy to use, precise and low cost rapid Point-Of-Care tests to detect wide array of different diseases.


Selfdiagnostics offers the world’s smallest application of PCR technology to create tests that you can use in the comfort of your own home, without the need to see a doctor.


Selfdiagnostics is also medical equipment distributor, mainly in EU region.


SelfDiagnostics Deutschland GmbH

Deutscher Platz 5 d
04103 Leipzig, Germany

Phone:
+49 341 355 238 511

covid19[at]selfdiagnostics.com

Contact us

    Subject:

    • Formerly, known as the ‘2019 novel coronavirus’ or ‘2019-nCoV.’ The COVID-19 virus is linked to the same family of viruses as Severe Acute Respiratory Syndrome (SARS) and some types of the common cold.